Yiguanjian cataplasm attenuates opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome

被引:0
作者
Gao Shuai [1 ]
Gao Hong [2 ]
Fan Yuchen [1 ,3 ]
Zhang Guanghua [2 ]
Sun Fengkai [1 ]
Zhao Jing [1 ]
Li Feng [1 ]
Yang Yang [1 ]
Wang Kai [1 ,3 ]
机构
[1] Department of Hepatology,Qilu Hospital of Shandong University
[2] Institute of Hepatology,Shandong University
[3] Research Center for Material Evidence Identification,Shandong Public Security Bureau
关键词
Yi Guan Jian; Paste; Morphine; Nalox one; Opioid dependence;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
OBJECTIVE:To investigate the effect of Yiguanjian(YGJ) cataplasm on the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.METHODS:One hundred Swiss albino mice,of equal male to female ratio,were randomly and equally divided into 10 groups.A portion(3 cm2) of the backside hair of the mice was removed 1 day prior to the experiment.Morphine(5 mg/kg) was intraperitoneally administered twice daily for 5days.YGJ cataplasm was prepared and pasted on the bare region of the mice immediately beforemorphine administration on day 3 and subsequently removed at the end day 5.On day 6,naloxone(8mg/kg) was intraperitoneally injected to precipitate opioid withdrawal syndrome.Behavioral observation was performed in two 30-min phases immediately after naloxone injection.RESULTS:The YGJ cataplasm significantly and dose-dependently attenuated morphine-naloxone-induced experimental opioid withdrawal,in terms of withdrawal severity score and the frequencies of jumping,rearing,forepaw licking,and circling behaviors.However,YGJ cataplasm treatment did not alter the acute analgesic effect of morphine.CONCLUSION:YGJ cataplasm could attenuate opioid dependence and its associated withdrawal symptoms.Therefore,YGJ cataplasm could serve as a potential therapy for opioid addiction in the future.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 36 条
  • [21] The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects
    Wand, Gary S.
    Weerts, Elise M.
    Kuwabara, Hiroto
    Wong, Dean F.
    Xu, Xiaoqiang
    McCaul, Mary E.
    ALCOHOL, 2012, 46 (06) : 511 - 517
  • [22] Rates of adequate reversal and symptoms of opioid withdrawal syndrome (OWS) in patients treated initially with low dose naloxone or high dose naloxone
    Purssell, Roy
    Godwin, Jesse
    Moe, Jessica
    Buxton, Jane
    Kestler, Andrew
    Crabtree, Alexis
    Scheuermeyer, Frank
    DeWitt, Chris
    Erdelyi, Shannon
    Balshaw, Robert
    Rowe, Adrianna
    Jiang, Andy
    Ng, Ben
    Cochrane, Christopher
    Risi, Alessia
    Ho, Vi
    Brubacher, Jeff
    CLINICAL TOXICOLOGY, 2019, 57 (10) : 875 - 876
  • [23] Buprenorphine induced opioid withdrawal syndrome relieved by adjunctive Magnesium: A clinical trial
    Moshiri, Mohammad
    Chaeideh, Bita
    Ebrahimi, Mohsen
    Dadpour, Bita
    Ghodsi, Alireza
    Haghighizadeh, Atoosa
    Etemad, Leila
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 160
  • [24] The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects
    Wand, Gary S.
    Weerts, Elise M.
    Kuwabara, Hiroto
    Wong, Dean F.
    Xu, Xiaoqiang
    McCaul, Mary E.
    ADDICTION BIOLOGY, 2013, 18 (01) : 181 - 192
  • [25] The use of buprenorphine plus naloxone sublingual tablet in the treatment of neonatal opioid withdrawal syndrome: Two case reports
    Ulu, Ersin
    Kandeger, Ali
    Meric, Ruya
    JOURNAL OF ADDICTIVE DISEASES, 2022, 40 (03) : 432 - 438
  • [26] Single and Combined Effects of Cannabigerol (CBG) and Cannabidiol (CBD) in Mouse Models of Oxaliplatin-Associated Mechanical Sensitivity, Opioid Antinociception, and Naloxone-Precipitated Opioid Withdrawal
    Hayduk, Sean A.
    Hughes, Amanda C.
    Winter, Rachel L.
    Milton, Mia D.
    Ward, Sara Jane
    BIOMEDICINES, 2024, 12 (06)
  • [27] Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain
    Miranda, Hugo F.
    Noriega, Viviana
    Zanetta, Pilar
    Carlos Prieto, Juan
    Carlos Prieto-Rayo, Juan
    Aranda, Nicolas
    Sierralta, Fernando
    JOURNAL OF BIOMEDICAL SCIENCE, 2014, 21
  • [28] In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Singh, Prabhat
    Sharma, Bhupesh
    Gupta, Surbhi
    Sharma, B. M.
    PSYCHOPHARMACOLOGY, 2015, 232 (02) : 465 - 475
  • [29] In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Prabhat Singh
    Bhupesh Sharma
    Surbhi Gupta
    B. M. Sharma
    Psychopharmacology, 2015, 232 : 465 - 475
  • [30] Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist
    Schulteis, Gery
    Chiang, David
    Archer, Clay
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 92 (01) : 157 - 163